“The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients” (2016) Radiology and Oncology, 50(3). Available at: https://www.radioloncol.com/index.php/ro/article/view/2546 (Accessed: 22 October 2026).